Our research into the impact of COVID-19 on cancer

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Icon of covid

Have feedback or questions on anything here?
Contact the team

When the UK entered “lockdown”, it became clear that cancer pathways would be impacted and therefore crucial to gather and monitor the evidence both in real time and the future. Cancer Research UK initiated a COVID-19 ‘Research & Analysis’ workstream to:  

  1. Understand research priorities 
  2. Co-ordinate and communicate COVID-19 research and analysis 
  3. Gather external intelligence 
  4. Identify any synergies and opportunities to collaborate 
  5. Monitor and review published evidence  

Together with the other COVID-19 workstreams happening across CRUK and our grant funded research, this work will inform how we support cancer patients, services and pathways through the pandemic and recovery and improving outcomes for the future.

Here’s a selection of the research we’ve been conducting and funding to better understand the impact of COVID-19 on the cancer pathway.

COVID and cancer key stats - Updated August 2021

Thumbnail image for CRUK Covid stats for august

COVID-19’s effect on cancer patients is a key concern to the cancer community with delayed or decreased diagnosis, tests and treatment. To understand this variable and rapidly changing landscape the Cancer Intelligence team are regularly monitoring published data around the impact of the pandemic across the cancer pathway. We have prepared some key insights which reports latest data across the UK (and where possible for the devolved nations) on screening, urgent suspected referrals, diagnostic tests and treatment. 

Cancer Intelligence Team, Cancer Research UK.

Evidence of the impact of COVID-19 across the cancer pathway: Key Stats

Updated August 2021.